Hydroxytyrosol Ameliorates Endothelial Function under Inflammatory Conditions by Preventing Mitochondrial...

Area of Science:

• Mitochondrial biology
• Endothelial dysfunction
• Antioxidant research

Background:

• Mitochondrial dysfunction contributes to endothelial dysfunction and vascular diseases.
• Hydroxytyrosol (HT), an olive oil antioxidant, benefits vascular health but its role in mitochondrial oxidative stress is unclear.
• Endothelial dysfunction involves inflammation, oxidative stress, and pathological angiogenesis.

Purpose of the Study:

• To investigate the effects of hydroxytyrosol (HT) on mitochondrial reactive oxygen species (ROS) production in an in vitro model of endothelial dysfunction.
• To determine if HT can ameliorate mitochondrial oxidative stress and improve mitochondrial function in inflamed endothelial cells.
• To explore HT's impact on inflammatory angiogenesis and mitochondrial biogenesis.

Main Methods:

• Utilized an in vitro model of endothelial dysfunction using cultured endothelial cells challenged with phorbol myristate acetate (PMA).
• Pretreated cells with varying concentrations of HT (1-30 μmol/L) to assess its effects.
• Measured mitochondrial superoxide production, lipid peroxidation, superoxide dismutase activity, mitochondrial membrane potential, ATP synthesis, and expression of key mitochondrial biogenesis factors.

Main Results:

• HT pretreatment suppressed inflammatory angiogenesis in PMA-challenged endothelial cells.
• HT reduced mitochondrial superoxide production and lipid peroxidation while increasing superoxide dismutase activity.
• HT improved mitochondrial function by restoring mitochondrial membrane potential, ATP synthesis, and ATP5β expression.
• HT promoted mitochondrial biogenesis by increasing mitochondrial DNA content and the expression of PGC-1α, NRF-1, and TFAM.

Conclusions:

• Hydroxytyrosol (HT) effectively blunts endothelial dysfunction and pathological angiogenesis by ameliorating mitochondrial function and oxidative stress.
• HT acts as a mitochondria-targeting antioxidant in inflamed endothelial cells.
• These findings suggest HT's potential as a therapeutic agent for vascular diseases associated with endothelial dysfunction.